Search

Displaying results 6901 - 6910 of 8517 in total
  1. Drug

    Labuxtinib

    go.drugbank.com/drugs/DB21658
    Experimental

    Labuxtinib has a monoisotopic molecular weight of 377.13 Da.

  2. Drug

    Trimoprostil

    go.drugbank.com/drugs/DB19935
    Experimental

    Trimoprostil has a monoisotopic molecular weight of 378.28 Da.

  3. Drug

    Nifuroquine

    go.drugbank.com/drugs/DB19999
    Experimental

    Nifuroquine has a monoisotopic molecular weight of 300.04 Da.

  4. Drug

    Semparatide

    go.drugbank.com/drugs/DB20016
    Experimental

    Semparatide has a monoisotopic molecular weight of 4002.26 Da.

  5. Drug

    Brobactam

    go.drugbank.com/drugs/DB20131
    Experimental

    Brobactam has a monoisotopic molecular weight of 278.96 Da.

  6. Drug

    Fandosentan

    go.drugbank.com/drugs/DB20193
    Experimental

    Fandosentan has a monoisotopic molecular weight of 517.08 Da.

  7. Drug

    D-Tryptophan

    go.drugbank.com/drugs/DB03225
    Experimental

    Tryptophan is one of the 20 standard amino acids, as well as an essential amino acid in the human diet. It is encoded in the standard genetic code as the codon UGG. … It is an essential amino acid as defined by its growth effects on rats.

  8. Drug

    Amitraz

    go.drugbank.com/drugs/DB11373
    ExperimentalVet approved

    It was generated in 1969 by the Boots Co. in England. Amitraz presents insect repellent effects and hence, it can be used as an insecticide and pesticide.

    Synonyms: N,N'-(methyliminodimethylidyne)bis-2,4-xylidine
  9. Drug

    IMM101

    go.drugbank.com/drugs/DB15851
    Experimental

    It has shown to be safe and well tolerated to complement conventional cancer therapy for patients with melanoma and pancreatic ductal adenocarcinoma [PMID: 21930686; PMID: 30107850; PMID: 27599039]. … As of July 2020, researchers from the Ottawa Hospital and Queen’s University, in partnership with the Canadian Cancer Society-funded Canadian Cancer Trials Group (CCTG), are conducting a trial in over

  10. Drug

    3,3'-diindolylmethane

    go.drugbank.com/drugs/DB11875
    Investigational

    Diindolylmethane has been used in trials studying the prevention and treatment of SLE, Prostate Cancer, Cervical Dysplasia, Stage I Prostate Cancer, and Stage II Prostate Cancer, among others.